Caitlin Cronin
Stock Analyst at Canaccord Genuity
(2.19)
# 1,424
Out of 4,479 analysts
8
Total ratings
50%
Success rate
-1.26%
Average return
Main Sectors:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN AxoGen | Reiterates: Buy | $15 | $7.52 | +99.47% | 2 | Jun 20, 2024 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $25 | $9.90 | +152.53% | 1 | Mar 20, 2024 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Hold | $130 | $106.27 | +22.33% | 1 | Feb 23, 2024 | |
| ENOV Enovis | Maintains: Buy | $73 → $75 | $44.71 | +67.75% | 1 | Feb 23, 2024 | |
| INMD InMode | Reiterates: Hold | $22 | $17.41 | +26.36% | 1 | Dec 7, 2023 | |
| KRMD KORU Medical Systems | Reiterates: Buy | $3 | $2.27 | +32.16% | 1 | Dec 7, 2023 | |
| RBOT Vicarious Surgical | Downgrades: Hold | $270 → $12 | $6.56 | +82.93% | 1 | Nov 14, 2023 |
AxoGen
Jun 20, 2024
Reiterates: Buy
Price Target: $15
Current: $7.52
Upside: +99.47%
Alphatec Holdings
Mar 20, 2024
Reiterates: Buy
Price Target: $25
Current: $9.90
Upside: +152.53%
Zimmer Biomet Holdings
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $106.27
Upside: +22.33%
Enovis
Feb 23, 2024
Maintains: Buy
Price Target: $73 → $75
Current: $44.71
Upside: +67.75%
InMode
Dec 7, 2023
Reiterates: Hold
Price Target: $22
Current: $17.41
Upside: +26.36%
KORU Medical Systems
Dec 7, 2023
Reiterates: Buy
Price Target: $3
Current: $2.27
Upside: +32.16%
Vicarious Surgical
Nov 14, 2023
Downgrades: Hold
Price Target: $270 → $12
Current: $6.56
Upside: +82.93%